Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Stock Market
Aerospace & Defense
Economic Indicators
Government
Non-Profits
Corporate Performance
Executive Activities
Commodities & Futures
Infectious Disease
Internet Media, Content & Design
Table bottom

Hematology
Sepsis has been a medical burden as a result of the number of people infected, the level of antibiotic resistance increases over time and the mortality remains high. The diagnosis of NKH is based on the "gold" standard of positive blood culture....
Euclid Tenders Info, 9:33pm ET



The "Sickle Cell Anemia Pipeline Highlights - 2018" report has been added to ResearchAndMarkets.com's offering. This report provides the most up-to-date information on key pipeline products in the global Sickle Cell...
BusinessWire, 1:13pm ET

Global biotherapeutics leader CSL Behring today announced that it will host an Industry Therapeutic Update at the 2018 annual meeting of the American Academy of Neurology (AAN) which will focus on neuromuscular medical research from the PATH...
PR Newswire, 8:43am ET

NEW YORK and CLEVELAND, April 20, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases,...
Globe Newswire, 8:23am ET

Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced today that the European Medicines Agency (EMA)...
GlobeNewswire, 8:23am ET

SmarTrend identified an Uptrend for Amag Pharmaceuti (NASDAQ:AMAG) on February 15th, 2018 at $17.20. In approximately 2 months, Amag Pharmaceuti has returned 15.41% as of today's recent price of $19.85. In the past 52 weeks, shares of...
Comtex SmarTrend(R), 1:28am ET

1-6 of 6


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.